WHO Backs GLP-1 Treatments To Tackle Obesity Epidemic
A new generation of appetite-suppressing drugs called GLP-1 agonists — which includes blockbuster brands Ozempic and Mounjaro — has become massively popular in recent years.
Uncensored & Undaunted
Find Us Here
Mwanzo Tv News